Pharmacogenomics has recently become an integral part of the drug development process.
The pharmacogenomics revolution comes at a time when pharmaceutical companies are …

Within the pharmaceutical industry, the application of clinical pharmacogenomics promises
to enhance the discovery of drug response markers, reduce the size and expense of clinical …

The human genome project and related research initiatives have enabled the identification
of a significant number of genetic variants that are predictive of drug response and outcome …

Pharmacogenomics is an important aspect of clinical genomics that is touching an
increasingly large number of patients. That is because pharmacogenomic testing is being …

Much of the inter-individual variability in drug efficacy and risk of adverse reactions is due to
polymorphisms in genes encoding proteins involved in drug pharmacokinetics and …

The mapping of the human genome and subsequent advancements in genetic technology
had provided clinicians and scientists an understanding of the genetic basis of altered drug …

The study of the genetics of drug responses has a long history but has provided only a few
examples of gene variants that are relevant clinically. Here, we discuss the current state of …

Utilization of pharmacogenomic information has the potential to significantly improve
treatment outcome and markedly reduce the rate of attrition of drugs in clinical development …

Pharmacogenomics is a growing field of research that links genetic variation with drug
effects to determine impact on pharmacology and clinical application. Relationships …

Understanding the role genes and genetic variants play in clinical treatment response
continues to be an active area of research with the goal of common clinical use. This goal …